Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s ...
ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s diseaseONAPGO is a wearable subcutaneous infusion ...
Oral Solid Dosage Contract Manufacturing Market is Expected to Reach a Valuation of US ...
Rising Prevalence of Chronic Diseases Spurs Demand for Oral Solid Dosage Formulations, Compelling Market GrowthRockville, MD, Feb. 04, 2025 (GLOBE NEWSWIRE) -- The global oral solid dosage contract ...